Dampening Enthusiasm for Circulating MicroRNA in Breast Cancer

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Leidner, Rom S ^a,b   Li, Li ^a,b   Thompson, Cheryl L ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 1179; MICRORNA 1238; MICRORNA 127 3P; MICRORNA 1295; MICRORNA 187; MICRORNA 193B; MICRORNA 200A; MICRORNA 202; MICRORNA 30B; MICRORNA 30C 2; MICRORNA 33B; MICRORNA 34C 5P; MICRORNA 376A; MICRORNA 376B; MICRORNA 376C; MICRORNA 379; MICRORNA 380; MICRORNA 490 3P; MICRORNA 568; MICRORNA 587; MICRORNA 612; MICRORNA 623; MICRORNA 654 5P; MICRORNA 671 3P; MICRORNA 708; MICRORNA 876 5P; MICRORNA 92B; MICRORNA1197; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; ARTICLE; BLOOD CELL; BREAST CANCER; CANCER PATIENT; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; LUNG CANCER; MAMMOGRAPHY; NUCLEOTIDE SEQUENCE; PLASMA; REPRODUCIBILITY; RNA SEQUENCE; SYSTEMATIC REVIEW; AGED; BLOOD; BREAST TUMOR; EARLY DIAGNOSIS; FACTUAL DATABASE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED;

ADULT; AGED; BREAST NEOPLASMS; DATABASES, FACTUAL; EARLY DETECTION OF CANCER; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MICRORNAS; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 84874608829     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057841     Document Type: Article

References (44)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
2. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, et al. (2009) Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 151: 727-737.
3. Calogne N, Petitti DB, DeWitt TG, Dietrich AJ, Gregory KD, et al. (2009) Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 15: 716-726, W-236.
4. Gierisch JM, O'Neill SC, Rimer BK, DeFrank JT, Bowling JM, et al. (2009) Factors associated with annual-interval mammography for women in their 40s. Cancer Epidemiol 33: 72-78.
5. Kee F, Telford AM, Donaghy P, O'Doherty A, (1992) Attitude or access: reasons for not attending mammography in Northern Ireland. Eur J Cancer Prev 1: 311-315.
6. Lee RC, Ambros V, (2001) An extensive class of small RNAs in Caenorhabditis elegans. Science 294: 862-864.
7. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
8. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101: 2999-3004.
9. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
10. Qian B, Katsaros D, Lu L, Preti M, Durando A, et al. (2009) High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1. Breast Cancer Res Treat 117: 131-140.
11. Zhou M, Liu Z, Zhao Y, Ding Y, Liu H, et al. (2010) MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1). J Biol Chem 285: 21496-21507.
12. Cascio S, D'Andrea A, Ferla R, Surmacz E, Gulotta E, et al. (2010) miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells. J Cell Physiol 224: 242-249.
13. Di Leva G, Gasparini P, Piovan C, Ngankeu A, Garofalo M, et al. (2010) MicroRNA Cluster 221-222 and Estrogen Receptor {alpha} Interactions in Breast Cancer. J Natl Cancer Inst 102: 706-721.
14. Li X, Mertens-Talcott SU, Zhang S, Kim KH, Ball J, et al. (2010) MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells. Endocrinology 151: 2462-2473.
15. Kong W, He L, Coppola M, Guo J, Esposito NN, et al. (2010) MicroRNA-155 regulates cell survival, growth and chemosensitivity by targeting FOXO3a in breast cancer. J Biol Chem 285: 17869-17879.
16. Jiang S, Zhang HW, Lu MH, He XH, Li Y, et al. (2010) MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res 70: 3119-3127.
17. Iorio MV, Croce CM, (2009) MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 27: 5848-5856.
18. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
19. Zhu W, Qin W, Atasoy U, Sauter ER, (2009) Circulating microRNAs in breast cancer and healthy subjects. BMC Res Notes 2: 89.
20. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, et al. (2010) Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer. Ann Surg 251: 499-505.
21. Heneghan HM, Miller N, Kelly R, Newell J, Kerin MJ, (2010) Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. Oncologist 15: 673-682.
22. Roth C, Rack B, Muller V, Janni W, Pantel K, et al. (2010) Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res 12: R90.
23. Wang F, Zheng Z, Guo J, Ding X, (2010) Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. Gynecol Oncol 119: 586-593.
24. Appaiah HN, Goswami CP, Mina LA, Badve S, Sledge GW Jr, et al. (2011) Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients. Breast Cancer Res 13: R86.
25. Asaga S, Kuo C, Nguyen T, Terpenning M, Giuliano AE, et al. (2011) Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin Chem 57: 84-91.
26. Wu Q, Lu Z, Li H, Lu J, Guo L, et al. (2011) Next-generation sequencing of microRNAs for breast cancer detection. J Biomed Biotechnol 2011: 597145.
27. van Schooneveld E, Wouters MC, Van der Auwera I, Peeters DJ, Wildiers H, et al. (2012) Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers. Breast Cancer Res 14: R34.
28. Schwarzenbach H, Milde-Langosch K, Steinbach B, Muller V, Pantel K, (2012) Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients. Breast Cancer Res Treat 134: 933-941.
29. Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, et al. (2012) Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila) 5: 492-497.
30. Kirschner MB, Kao SC, Edelman JJ, Armstrong NJ, Vallely MP, et al. (2011) Haemolysis during sample preparation alters microRNA content of plasma. PLoS One 6: e24145.
31. McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A, (2012) Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 57: 833-840.
32. Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, et al. (2010) A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One 5: e13735.
33. Sieuwerts AM, Mostert B, Bolt-de Vries J, Peeters D, de Jongh FE, et al. (2011) mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients. Clin Cancer Res 17: 3600-3618.
34. Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, et al. (2012) Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. PLoS One 7: e29770.
35. Hu Z, Dong J, Wang LE, Ma H, Liu J, et al. (2012) Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls. Carcinogenesis 33: 828-834.
36. Wu Q, Wang C, Lu Z, Guo L, Ge Q, (2012) Analysis of serum genome-wide microRNAs for breast cancer detection. Clin Chim Acta 413: 1058-1065.
37. Thompson CL, Larkin EK, Patel S, Berger NA, Redline S, et al. (2011) Short duration of sleep increases risk of colorectal adenoma. Cancer 117: 841-847.
38. Ortiz AP, Thompson CL, Chak A, Berger NA, Li L, (2012) Insulin resistance, central obesity, and risk of colorectal adenomas. Cancer 118: 1774-1781.
39. Duttagupta R, Jiang R, Gollub J, Getts RC, Jones KW, (2011) Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures. PLoS One 6: e20769.
40. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, et al. (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 108: 5003-5008.
41. Wang K, Yuan Y, Cho JH, McClarty S, Baxter D, et al. (2012) Comparing the MicroRNA spectrum between serum and plasma. PLoS One 7: e41561.
42. Pritchard CC, Cheng HH, Tewari M, (2012) MicroRNA profiling: approaches and considerations. Nat Rev Genet 13: 358-369.
43. Meyer SU, Pfaffl MW, Ulbrich SE, (2010) Normalization strategies for microRNA profiling experiments: a 'normal' way to a hidden layer of complexity? Biotechnol Lett 32: 1777-1788.
44. Meyer SU, Kaiser S, Wagner C, Thirion C, Pfaffl MW, (2012) Profound Effect of Profiling Platform and Normalization Strategy on Detection of Differentially Expressed MicroRNAs- A Comparative Study. PLoS One 7: e38946.